| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 180,600 | $1 | $722.4K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,600 | $30 | $258.4K |
| J0897 | Injection, denosumab, 1 mg | 13,380 | $20 | $240.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,230 | $30 | $84K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 730 | $100 | $70.4K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 6,600 | $10 | $66K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 930 | $70 | $63.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $120 | $37.3K |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 50 | $550 | $28.8K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 210 | $60 | $12.1K |